Heartbeam Inc./$BEAT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Ticker
$BEAT
Sector
Primary listing
Employees
16
Headquarters
Website
Heartbeam Inc. Metrics
BasicAdvanced
$72M
-
-$0.66
-0.58
-
Price and volume
Market cap
$72M
Beta
-0.58
52-week high
$4.00
52-week low
$0.54
Average daily volume
22M
Financial strength
Current ratio
0.861
Quick ratio
0.751
Profitability
Management effectiveness
Return on assets (TTM)
-272.38%
Return on equity (TTM)
-792.01%
Valuation
Price to book
175.94
Price to tangible book (TTM)
175.94
Price to free cash flow (TTM)
-4.234
Free cash flow yield (TTM)
-23.62%
Free cash flow per share (TTM)
-0.491
Growth
Earnings per share change (TTM)
-5.11%
3-year earnings per share growth (CAGR)
-23.96%
Heartbeam Inc. News
AllArticlesVideos
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
Business Wire·2 weeks ago
Why Is Micro Cap HeartBeam Stock Surging On Wednesday?
Benzinga·1 month ago
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Heartbeam Inc. stock?
Heartbeam Inc. (BEAT) has a market cap of $72M as of January 20, 2026.
What is the P/E ratio for Heartbeam Inc. stock?
The price to earnings (P/E) ratio for Heartbeam Inc. (BEAT) stock is 0 as of January 20, 2026.
Does Heartbeam Inc. stock pay dividends?
No, Heartbeam Inc. (BEAT) stock does not pay dividends to its shareholders as of January 20, 2026.
When is the next Heartbeam Inc. dividend payment date?
Heartbeam Inc. (BEAT) stock does not pay dividends to its shareholders.
What is the beta indicator for Heartbeam Inc.?
Heartbeam Inc. (BEAT) has a beta rating of -0.58. This means that it has an inverse relation to market volatility.